These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 7515834)

  • 1. Neuropeptide Y-induced mast cell activation.
    Cross LJ; Beck-Sickinger AG; Beyerman M; Krause E; Bienert M; Ennis M
    Biochem Soc Trans; 1994 Feb; 22(1):7S. PubMed ID: 7515834
    [No Abstract]   [Full Text] [Related]  

  • 2. Structural requirements for neuropeptide Y in mast cell and G protein activation.
    Mousli M; Trifilieff A; Pelton JT; Gies JP; Landry Y
    Eur J Pharmacol; 1995 Mar; 289(1):125-33. PubMed ID: 7540143
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of alpha-helicity, amphipathicity and D-amino acid incorporation on the peptide-induced mast cell activation.
    Cross LJ; Ennis M; Krause E; Dathe M; Lorenz D; Krause G; Beyermann M; Bienert M
    Eur J Pharmacol; 1995 Nov; 291(3):291-300. PubMed ID: 8719413
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuropeptide Y and truncated neuropeptide Y analogs evoke histamine release from rat peritoneal mast cells. A direct effect on G proteins?
    Grundemar L; Krstenansky JL; Håkanson R
    Eur J Pharmacol; 1994 Jun; 258(1-2):163-6. PubMed ID: 7523149
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure activity studies of mast cell activation and hypotension induced by neuropeptide Y (NPY), centrally truncated and C-terminal NPY analogues.
    Cross LJ; Beck-Sickinger AG; Bienert M; Gaida W; Jung G; Krause E; Ennis M
    Br J Pharmacol; 1996 Jan; 117(2):325-32. PubMed ID: 8789386
    [TBL] [Abstract][Full Text] [Related]  

  • 6. C-terminal neuropeptide Y fragments are mast cell-dependent vasodepressor agents.
    Shen GH; Grundemar L; Zukowska-Grojec Z; Håkanson R; Wahlestedt C
    Eur J Pharmacol; 1991 Nov; 204(3):249-56. PubMed ID: 1723049
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuropeptide Y, peptide YY and C-terminal fragments release histamine from rat peritoneal mast cells.
    Grundemar L; Håkanson R
    Br J Pharmacol; 1991 Dec; 104(4):776-8. PubMed ID: 1725763
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of positive charges of neuropeptide Y fragments in mast cell activation.
    Mousli M; Landry Y
    Agents Actions; 1994 Jun; 41 Spec No():C41-2. PubMed ID: 7526655
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human and rat cutaneous mast cells: involvement of a G protein in the response to peptidergic stimuli.
    Emadi-Khiav B; Mousli M; Bronner C; Landry Y
    Eur J Pharmacol; 1995 Jan; 272(1):97-102. PubMed ID: 7536161
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bradykinin analog induce histamine release from human skin mast cells.
    Lawrence ID; Warner JA; Cohan VL; Lichtenstein LM; Kagey-Sobotka A; Vavrek RJ; Stewart JM; Proud D
    Adv Exp Med Biol; 1989; 247A():225-9. PubMed ID: 2481386
    [No Abstract]   [Full Text] [Related]  

  • 11. Synthesis and biological properties of 4-norleucine-neuropeptide Y; secondary structure of neuropeptide Y.
    Balasubramaniam A; Renugopalakrishnan V; Rigel DF; Nussbaum MS; Rapaka RS; Dobbs JC; Carreira LA; Fischer JE
    Biochim Biophys Acta; 1989 Aug; 997(3):176-81. PubMed ID: 2765554
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Naturally occurring aliphatic polyamines-induced histamine release from rat peritoneal mast cells].
    Uno D; Kurosawa M
    Arerugi; 1991 Apr; 40(4):470-5. PubMed ID: 1713028
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The modulatory effects of WE-14 on histamine release from rat peritoneal mast cells.
    Forsythe P; Curry WJ; Johnston CF; Harriott P; MacMahon J; Ennis M
    Inflamm Res; 1997 Mar; 46 Suppl 1():S13-4. PubMed ID: 9098742
    [No Abstract]   [Full Text] [Related]  

  • 14. [Ketotifen, a selective histamine liberator].
    Gushchin IS; Deriugin IL
    Biull Eksp Biol Med; 1979 Nov; 88(11):597-9. PubMed ID: 94270
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Manipulating Y receptor subtype activation of short neuropeptide Y analogs by introducing carbaboranes.
    Hofmann S; Frank R; Hey-Hawkins E; Beck-Sickinger AG; Schmidt P
    Neuropeptides; 2013 Apr; 47(2):59-66. PubMed ID: 23352609
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of adenosine and its analogues on histamine release from mast cells.
    Dexter EJ; Butchers PR; Reeves JJ; Sheehan MJ; Pearce FL
    Inflamm Res; 1999 Apr; 48 Suppl 1():S7-8. PubMed ID: 10350137
    [No Abstract]   [Full Text] [Related]  

  • 17. The exogenous lipid requirement for histamine release from rat peritoneal mast cells stimulated by concanavalin A.
    Smith GA; Hesketh TR; Plumb RW; Metcalfe JC
    FEBS Lett; 1979 Sep; 105(1):58-62. PubMed ID: 90622
    [No Abstract]   [Full Text] [Related]  

  • 18. Carnosine attenuates mast cell degranulation and histamine release induced by oxygen-glucose deprivation.
    Shen Y; Zhang S; Fu L; Hu W; Chen Z
    Cell Biochem Funct; 2008 Apr; 26(3):334-8. PubMed ID: 18064721
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Somatostatin induces histamine secretion from rat peritoneal mast cells.
    Theoharides TC; Douglas WW
    Endocrinology; 1978 May; 102(5):1637-40. PubMed ID: 84750
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of the binding site of neuropeptide Y to the rabbit kidney receptor using multiple peptide synthesis.
    Beck-Sickinger AG; Dürr H; Hoffmann E; Gaida W; Jung G
    Biochem Soc Trans; 1992 Nov; 20(4):847-50. PubMed ID: 1487078
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.